Glioblastoma

Showing NaN - NaN of 55

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Targeted Pediatric High-Grade Glioma Therapy

Not yet recruiting
  • High Grade Glioma
  • +8 more
    • Aurora, Colorado
    • +17 more
    May 1, 2023

    Standard Radiotherapy and TMZ Patients With GBM

    Not yet recruiting
    • Glioblastoma
    • Glioma, Malignant
      • Durham, North Carolina
        The Preston Robert Tisch Brain Tumor Center at Duke University
      Jan 20, 2023

      Anaplastic Astrocytoma, Glioblastoma, Malignant Glioma Trial in Worldwide (Radiation Therapy, Temozolomide, Veliparib)

      Active, not recruiting
      • Anaplastic Astrocytoma
      • +2 more
      • Radiation Therapy
      • +2 more
      • Birmingham, Alabama
      • +162 more
      Dec 30, 2022

      Pancreatic Cancer, Small Bowel Cancer, Colorectal Cancer Trial in United States (Ulixertinib (BVD-523))

      Available
      • Pancreatic Cancer
      • +20 more
      • Ulixertinib (BVD-523)
      • Birmingham, Alabama
      • +25 more
      Nov 4, 2022

      Malignant Glioma, Glioblastoma Trial in Durham (Evolocumab)

      Recruiting
      • Malignant Glioma
      • Glioblastoma
      • Durham, North Carolina
        Duke University Medical Center
      Oct 13, 2022

      Advanced Malignant Solid Tumor, Glioblastoma, Recurrent Cholangiocarcinoma Trial in United States (Olaparib)

      Recruiting
      • Advanced Malignant Solid Neoplasm
      • +6 more
      • Costa Mesa, California
      • +49 more
      Aug 24, 2022

      Glioblastoma Trial in Durham (Human CMV pp65-LAMP mRNA-pulsed autologous DCs containing GM CSF, Temozolomide, Tetanus-Diphtheria

      Suspended
      • Glioblastoma
      • Human CMV pp65-LAMP mRNA-pulsed autologous DCs containing GM CSF
      • +4 more
      • Durham, North Carolina
        Duke University Medical Center
      Aug 16, 2022

      Marrow and Blood in Patients With Glioblastoma

      Not yet recruiting
      • Glioblastoma
      • Biorepository
      • Durham, North Carolina
        Duke University Medical Center
      Jul 28, 2022

      GBM, Glioblastoma, Glioma Trial in Durham (Recombinant nonpathogenic polio-rhinovirus chimera (PVSRIPO))

      Completed
      • GBM
      • +3 more
      • Recombinant nonpathogenic polio-rhinovirus chimera (PVSRIPO)
      • Durham, North Carolina
        Duke University Medical Center
      Jun 28, 2022

      Glioblastoma, Melanoma Stage IV, Melanoma Recurrent Trial in United Kingdom, United States (ST101)

      Recruiting
      • Glioblastoma
      • +11 more
      • San Francisco, California
      • +11 more
      Jul 13, 2022

      Glioblastoma Trial in Durham (PVSRIPO)

      No longer available
      • Glioblastoma
      • PVSRIPO
      • Durham, North Carolina
        Duke University Medical Center
      Jun 23, 2022

      Malignant Glioma, Glioblastoma Trial in Durham (hEGFRvIII-CD3 (BRiTE), Activated Cell Therapy)

      Not yet recruiting
      • Malignant Glioma
      • Glioblastoma
      • hEGFRvIII-CD3 (BRiTE)
      • Activated Cell Therapy
      • Durham, North Carolina
        Duke University Medical Center
      Jun 24, 2022

      Glioblastoma, Glioma, Malignant Trial in Durham (MT-201-GBM monocyte vaccine)

      Not yet recruiting
      • Glioblastoma
      • Glioma, Malignant
      • MT-201-GBM monocyte vaccine
      • Durham, North Carolina
        The Preston Robert Tisch Brain Tumor Center at Duke University M
      May 25, 2022

      Malignant Glioma, Glioblastoma, Gliosarcoma Trial in Durham (Bevacizumab, Temozolomide, Radiation Therapy (XRT))

      Completed
      • Malignant Glioma
      • +2 more
      • Durham, North Carolina
        The Preston Robert Tisch Brain Tumor Center at Duke
      Mar 29, 2022

      Glioblastoma, Astrocytoma, Grade IV, Giant Cell Glioblastoma Trial in Durham (Unpulsed DCs, Td, Human CMV pp65-LAMP mRNA-pulsed

      Completed
      • Glioblastoma
      • +3 more
      • Unpulsed DCs
      • +6 more
      • Durham, North Carolina
        Duke University Medical Center
      Jan 3, 2022

      Glioblastoma Multiforme, Glioblastoma, Malignant Glioma Trial in Gainesville, Orlando, Durham (pp65-shLAMP DC with GM-CSF,

      Recruiting
      • Glioblastoma Multiforme
      • +4 more
      • pp65-shLAMP DC with GM-CSF
      • +4 more
      • Gainesville, Florida
      • +2 more
      Jan 6, 2022

      Glioblastoma, Recurrent Glioblastoma, Supratentorial Glioblastoma Trial in United States (lerapolturev, pembrolizumab)

      Active, not recruiting
      • Glioblastoma
      • +3 more
      • lerapolturev
      • pembrolizumab
      • San Francisco, California
      • +9 more
      Nov 30, 2021

      Glioblastoma, Malignant Glioma Trial in Canada, Switzerland, United States (drug, radiation, device)

      Completed
      • Glioblastoma
      • Malignant Glioma
      • La Jolla, California
      • +7 more
      Apr 13, 2021

      Malignant Glioma, Grade 4 Malignant Glioma, Glioblastoma Trial in Durham (Radiation Therapy, Temozolomide, Bevacizumab)

      Completed
      • Malignant Glioma
      • +3 more
      • Radiation Therapy
      • +2 more
      • Durham, North Carolina
        Duke Cancer Center
      Jan 6, 2021

      Glioblastoma, Grade IV Astrocytoma, Glioblastoma Multiforme Trial in United States (MDNA55)

      Completed
      • Glioblastoma
      • +3 more
      • San Francisco, California
      • +6 more
      Jan 13, 2021

      Glioblastoma Trial in United States (Pembrolizumab, Bevacizumab)

      Completed
      • Glioblastoma
      • Los Angeles, California
      • +7 more
      Nov 30, 2020

      Malignant Melanoma, Medullary Thyroid Cancer, Glioblastoma Trial in United States (Rovalpituzumab tesirine, Dexamethasone)

      Terminated
      • Malignant Melanoma
      • +7 more
      • Gilbert, Arizona
      • +29 more
      Sep 21, 2020

      B-cell Malignancies, Colorectal Cancer (CRC), Head Neck Cancer Trial in United Kingdom, United States (Nivolumab (Phase 1),

      Completed
      • B-cell Malignancies
      • +7 more
      • Nivolumab (Phase 1)
      • +4 more
      • Birmingham, Alabama
      • +23 more
      Aug 26, 2020

      Glioblastoma, Gliosarcoma Trial in Durham (EGFRvIII CAR T cells)

      Terminated
      • Glioblastoma
      • Gliosarcoma
      • EGFRvIII CAR T cells
      • Durham, North Carolina
        The Preston Robert Tisch Brain Tumor Center at Duke
      Jul 8, 2020